Craig A. Collard

Insider Reports History

Location
Cary, NC
Signature
/s/Kathryn Lester Attorney-in-fact for Craig Collard
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Craig A. Collard:

Company Role Class Num Shares Value Price $ Report Date Ownership
HERON THERAPEUTICS, INC. /DE/ Chief Executive Officer, Director Common Stock 536,921 $697,997 $1.30 19 Jan 2026 Direct
TerrAscend Corp. Director Common Shares 1,076,538 $419,849 $0.3900 24 Jun 2025 Direct
HERON THERAPEUTICS, INC. /DE/ Chief Executive Officer, Director Restricted Stock Units 110,375 $330,000 $2.64 19 Jan 2026 Direct
HERON THERAPEUTICS, INC. /DE/ Chief Executive Officer, Director Employee Stock Option (Right to Buy) 1,113,240 31 Jan 2025 Direct
OPIANT PHARMACEUTICALS, INC. Director Common Stock 0 $20.00 02 Mar 2023 Direct
OPIANT PHARMACEUTICALS, INC. Director Stock Option (right to buy) 0 $10.00 02 Mar 2023 Direct
Sierra Oncology, Inc. Director Common Stock 0 $55.00 01 Jul 2022 Direct
Sierra Oncology, Inc. Director Stock Option (right to buy) 0 01 Jul 2022 Direct

Insider Reports Filed by Craig A. Collard

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Jan 2026 2 $0 4 Chief Executive Officer, Director 20 Jan 2026, 14:39
HRTX HERON THERAPEUTICS, INC. /DE/ 31 Oct 2025 2 $0 4 Chief Executive Officer, Director 04 Nov 2025, 12:31
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Oct 2025 2 $0 4 Chief Executive Officer, Director 21 Oct 2025, 11:23
HRTX HERON THERAPEUTICS, INC. /DE/ 31 Jul 2025 2 $0 4 Chief Executive Officer, Director 04 Aug 2025, 17:21
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Jul 2025 2 $0 4 Chief Executive Officer, Director 22 Jul 2025, 11:55
TSNDF TerrAscend Corp. 24 Jun 2025 1 $0 4 Director 25 Jun 2025, 16:57
HRTX HERON THERAPEUTICS, INC. /DE/ 30 Apr 2025 2 $0 4 Chief Executive Officer, Director 02 May 2025, 20:23
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Apr 2025 2 $0 4 Chief Executive Officer, Director 22 Apr 2025, 09:39
HRTX HERON THERAPEUTICS, INC. /DE/ 03 Apr 2025 2 $0 4 Chief Executive Officer, Director 03 Apr 2025, 17:48
TSNDF TerrAscend Corp. 25 Mar 2025 1 -$1,039 4 Director 26 Mar 2025, 17:06
HRTX HERON THERAPEUTICS, INC. /DE/ 31 Jan 2025 2 $0 4 Chief Executive Officer, Director 04 Feb 2025, 12:43
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Jan 2025 2 $0 4 Chief Executive Officer, Director 22 Jan 2025, 09:06
TSNDF TerrAscend Corp. 31 Dec 2024 1 -$46,608 4 Director 03 Jan 2025, 16:05
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Oct 2024 2 $0 4 Chief Executive Officer, Director 21 Oct 2024, 15:49
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Jul 2024 2 $0 4 Chief Executive Officer, Director 22 Jul 2024, 09:54
TSNDF TerrAscend Corp. 17 Jun 2024 3 $0 4 Director 20 Jun 2024, 17:30
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Apr 2024 2 $0 4 Chief Executive Officer, Director 19 Apr 2024, 16:34
HRTX HERON THERAPEUTICS, INC. /DE/ 03 Apr 2024 2 $0 4 Chief Executive Officer, Director 05 Apr 2024, 15:57
HRTX HERON THERAPEUTICS, INC. /DE/ 19 Jan 2024 2 $0 4 Chief Executive Officer, Director 19 Jan 2024, 20:58
HRTX HERON THERAPEUTICS, INC. /DE/ 16 Nov 2023 1 +$137,970 4 Chief Executive Officer, Director 17 Nov 2023, 12:37
HRTX HERON THERAPEUTICS, INC. /DE/ 22 Aug 2023 1 -$1,142 4 Chief Executive Officer, Director 24 Aug 2023, 16:09
TSNDF TerrAscend Corp. 22 Jun 2023 1 $0 4 Director 26 Jun 2023, 14:40
HRTX HERON THERAPEUTICS, INC. /DE/ 22 May 2023 1 -$1,002 4 Chief Executive Officer, Director 24 May 2023, 17:04
HRTX HERON THERAPEUTICS, INC. /DE/ 03 Apr 2023 3 $0 4 Chief Executive Officer, Director 05 Apr 2023, 17:10
/report/000138550823000075-collard-craig-a-2023-03-02 OPIANT PHARMACEUTICALS, INC. 02 Mar 2023 6 -$1,116,440 4 Director 03 Mar 2023, 08:25
HRTX HERON THERAPEUTICS, INC. /DE/ 22 Feb 2023 0 $0 3 Director 02 Mar 2023, 15:11
TSNDF TerrAscend Corp. 23 Sep 2022 1 $0 4 Director 27 Sep 2022, 12:00
TSNDF TerrAscend Corp. 22 Sep 2022 1 $0 4 Director 26 Sep 2022, 12:26
/report/000120919122040255-collard-craig-a-2022-07-01 Sierra Oncology, Inc. 01 Jul 2022 3 -$742,500 4 Director 01 Jul 2022, 16:37
TSNDF TerrAscend Corp. 27 Jun 2022 2 $0 4 Director 29 Jun 2022, 21:08
/report/000138550822000090-collard-craig-a-2022-06-14 OPIANT PHARMACEUTICALS, INC. 14 Jun 2022 1 $0 4 Director 14 Jun 2022, 17:00
/report/000138550822000076-collard-craig-a-2022-06-10 OPIANT PHARMACEUTICALS, INC. 10 Jun 2022 2 +$63,266 4 Director 13 Jun 2022, 16:55
/report/000138550822000061-collard-craig-a-2022-05-16 OPIANT PHARMACEUTICALS, INC. 16 May 2022 1 +$367,611 4 Director 17 May 2022, 16:02
/report/000138550822000058-collard-craig-a-2022-05-13 OPIANT PHARMACEUTICALS, INC. 13 May 2022 1 +$38,698 4 Director 16 May 2022, 16:05
TSNDF TerrAscend Corp. 06 Jan 2022 2 +$134,465 4 Director 10 Jan 2022, 20:30
TSNDF TerrAscend Corp. 01 Jan 2022 0 $0 3 Director 03 Jan 2022, 19:52
/report/000120919121066860-collard-craig-a-2021-11-23 Sierra Oncology, Inc. 23 Nov 2021 2 +$310,863 4 Director 24 Nov 2021, 18:07
/report/000138550821000131-collard-craig-a-2021-09-13 OPIANT PHARMACEUTICALS, INC. 13 Sep 2021 3 +$67,062 4 Director 15 Sep 2021, 16:01
/report/000138550821000126-collard-craig-a-2021-09-10 OPIANT PHARMACEUTICALS, INC. 10 Sep 2021 1 +$174,110 4 Director 13 Sep 2021, 16:08
/report/000138550821000083-collard-craig-a-2021-06-15 OPIANT PHARMACEUTICALS, INC. 15 Jun 2021 2 $0 4 Director 16 Jun 2021, 16:01
/report/000120919121039094-collard-craig-a-2021-06-08 Sierra Oncology, Inc. 08 Jun 2021 1 $0 4 Director 09 Jun 2021, 10:50